RNA Therapeutics and Oligonucleotides reposted this
Pleased to be able to share the topline results from our latest Phase III study, the first to show the effects of an siRNA therapy as a monotherapy in lowering cholesterol levels in patients at low or moderate risk of atherosclerotic cardiovascular disease. Thanks to all the V-MONO patients, investigators, site staff and Novartis scientists for making this possible.
Well done team Leqvio! And thank you.
Congrats Dominic! I hope you are well.
Outstanding results! Congratulations Dominic and Team!
Global Head Drug Dev, CVM at Novartis
2wCongrats Dominic and team!